BioLineRx (BLRX) Inventory (2023 - 2026)

BioLineRx's Inventory history runs 3 years deep, the most recent figure standing at $2.1 million for Q4 2025.

• In Q4 2025, Inventory fell 31.7% year-over-year to $2.1 million; the TTM figure through Dec 2025 stood at $2.1 million (down 31.7% YoY), while the FY2025 annual figure was $2.1 million, down 31.7% from the prior year.
• Inventory for Q4 2025 stood at $2.1 million, down from $2.2 million in the prior quarter.
• The five-year high for Inventory was $3.6 million in Q2 2024, with the low at $1.4 million in Q3 2023.
• The 3-year median for Inventory is $2.9 million (2024), against an average of $2.7 million.
• The sharpest annual moves came in 2024 and 2025: Inventory soared 162.13% in 2024, then sank 38.46% in 2025.
• BioLineRx's Inventory stood at $2.0 million in 2023, then soared by 61.03% to $3.1 million in 2024, then plunged by 31.7% to $2.1 million in 2025.
• Business Quant data shows BLRX's Inventory at $2.1 million in Q4 2025, $2.2 million in Q3 2025, and $2.8 million in Q2 2025.